Turbine, a prominent company focused on the virtualization of biological experiments using AI, has announced a partnership with AstraZeneca to evaluate the capability of Turbine’s platform in rationalizing the discovery of antibody-drug conjugates
Jubilant Pharmova declared that its wholly owned subsidiary, Jubilant HollisterStier LLC (JHS), a major contract manufacturer specializing in sterile injectables in the North American pharmaceutical industry
Integris Medtech is the second-biggest medical technology platform in India that is diversified. It has submitted the Draft Red Herring Prospectus (DRHP) to the Securities and Exchange Board of India
Tamil Nadu is under the spotlight after a spate of child deaths linked to adulterated cough syrup manufactured by Sresan Pharmaceuticals. The deaths have now increased to 23, as two more children, Garvik Pawar, and Mayank Suryawanshi
Thermo Fisher Scientific, has come up with a new lab test which needs to be developed locally, aimed at the better detection of lung transplant rejection and injury. The Molecular Microscope Diagnostic System for Lung
Bayer and Kumquat Biosciences, a clinical-stage biotech company established by pioneers in targeting the KRAS pathway, have announced the start of a Phase I clinical trial for KQB548, an investigational inhibitor aimed at treating KRAS G12D-mutated
Delhi High Court allows Natco Pharma to launch its generic version of Risdiplam for spinal muscular atrophy, offering it at nearly 90% lower price than Roche’s Evrysdi, marking a major win for affordable healthcare access...
Under the Ayushman Bharat framework, the Union government has continuously sought to improve the primary to tertiary care continuum. Comprehensive primary care is being ensured through more than 1.79 lakh Ayushman Arogya Mandirs, and infrastructure
AlphaMedix (212Pb-DOTAMTATE), an investigational somatostatin receptor (SSTR)-targeted alpha therapy using the lead-212 isotope, met all primary efficacy endpoints and demonstrated clinically meaningful overall response rates (ORR) and prolonged
Nanomi B.V. (Nanomi) announced that a pharmaceutical company of global repute Lupin Limited (Lupin) has established a new strategic alliance programme which would make the long-acting injectable (LAI) platform PrecisionSphere more accessible.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")